Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Prestige Consumer Healthcare Stock Quote

Prestige Consumer Healthcare (NYSE: PBH)

$68.35
(0.5%)
$0.32
Price as of April 18, 2024, 4:00 p.m. ET

Prestige Consumer Healthcare Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
PBH +10.87% +143.41% +19.45% +283%
S&P +20.88% +72.88% +11.56% +320%

Prestige Consumer Healthcare Company Info

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.

News & Analysis

The Fool has written over 100 articles on Prestige Consumer Healthcare.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.